Unique ID issued by UMIN | UMIN000000659 |
---|---|
Receipt number | R000000786 |
Scientific Title | Effect of ARB on ambulatory blood pressure and cardiovascular remodeling in hypertensives on hemodialysis |
Date of disclosure of the study information | 2008/11/01 |
Last modified on | 2015/09/19 09:52:20 |
Effect of ARB on ambulatory blood pressure and cardiovascular remodeling in hypertensives on hemodialysis
Effect of ARB on ambulatory blood pressure and cardiovascular remodeling in hypertensives on hemodialysis
Effect of ARB on ambulatory blood pressure and cardiovascular remodeling in hypertensives on hemodialysis
Effect of ARB on ambulatory blood pressure and cardiovascular remodeling in hypertensives on hemodialysis
Japan |
Hypertension, end-stage renal failure on hemodialysis
Medicine in general | Cardiology | Endocrinology and Metabolism |
Nephrology |
Others
NO
This study will examine a possible beneficial effect of ARB on ambulatory blood pressure profiles and cardiovascular remodeling in hypertensives on hemodialysis.
Efficacy
Confirmatory
Pragmatic
Phase IV
1) Ambulatory BP monitering (mean BP, BP and HR variability)
2) UCG, carotid echogram (IVSd, LVDd, LVPWd, LVDs, FS, EF, E/A, DcT, LAD, IMT)
3) ABI/baPWV
4) Blood chemistry
Endocrine: catecholamine, ANP, BNP, PRA, PAC
Coagulation: fibrinogen
Glucose: blood glucose, IRI
Serological: CRP
Oxidative stress: adiponectin, MDA-LDL, AGE
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
Active
YES
NO
Institution is not considered as adjustment factor.
NO
No need to know
2
Treatment
Medicine |
Losartan group: Start with once-daily dosing of losartan 25-50 mg, and increase up to 50-100 mg if effect of losartan on the clinical parameters is insufficient. Target blood pressure is less than 140/90 mmHg.
Control therapy group: Treated with anti-hypertensives principally by other than ARBs or ACE inhibitors.Target blood pressure is less than 140/90 mmHg.
20 | years-old | <= |
Not applicable |
Male and Female
Patients who just started mainetenance hemodialysis for ESRD with blood pressure>=140/90.
Malignancy, acute myocardial infarction/unstable angina, collagen diseases, acute renal failure, severe liver disorder, history of hypersensitivity to the administered ARB, pregnant women, or women suspected of being pregnant
60
1st name | |
Middle name | |
Last name | Kouichi TAMURA |
Yokohama City University School of Medicine
Deaprtment of Cardiorenal Medicine
3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, JAPAN
045-787-2635
tamukou@med.yokohama-cu.ac.jp
1st name | |
Middle name | |
Last name | kazuaki UCHINO |
Yokohama City University School of Medicine
Deaprtment of Cardiorenal Medicine
3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, JAPAN
045-787-2800
http://www-user.yokohama-cu.ac.jp/
uchinok@med.yokohama-cu.ac.jp
Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine
Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine
Self funding
Yokohama Minami-Kyosai Hospital, Kosaikai Asahi Hospital, Fujisawa Municipal Hospital
NO
2008 | Year | 11 | Month | 01 | Day |
Published
Completed
2004 | Year | 01 | Month | 01 | Day |
2004 | Year | 01 | Month | 01 | Day |
2011 | Year | 03 | Month | 01 | Day |
2012 | Year | 03 | Month | 01 | Day |
2012 | Year | 09 | Month | 01 | Day |
2013 | Year | 03 | Month | 01 | Day |
2007 | Year | 03 | Month | 28 | Day |
2015 | Year | 09 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000786